...a forum for the exchange of ideas and information that will continue to frame directions for future research and treatment.
Chicago, Ill. (PRWEB) April 30, 2013
The Eighth European International Kidney Cancer Symposium will be webcast live from Budapest, May 3rd and 4th, 2013. Bringing together key individuals and representatives from leading laboratories and centers working with renal cell carcinoma, this symposium seeks to provide a forum for the exchange of ideas and information that will continue to frame directions for future research and treatment.
The meeting is supported by grants from Pfizer Oncology, Astellas Oncology – AVEO Pharmaceuticals, Inc., Novartis Oncology, and Bayer HealthCare. Some presentations will be streamed live from the Budapest Marriott Hotel.
On May 2nd, a select group of patient advocates will gather at the same venue for the inaugural meeting of the International Kidney Cancer Congress. This half-day seminar is focused on the issues and challenges associated with patient participation in clinical trials. The meeting is chaired by Kidney Cancer Association (KCA) Chair Emeritus Paula Bowen, and the faculty includes some of the same internationally recognized experts who will speak the following day at the Kidney Cancer Symposium. This webcast is scheduled to begin at approximately 12:15 p.m. local time.
KCA is a global charity composed of patients, family members, physicians, researchers, and other health professionals. It is the world’s first international charity dedicated specifically to the eradication of death and suffering from renal cancers. It is also by far the largest organization of its kind, with members in more than 100 countries. It funds, promotes, and collaborates with the National Cancer Institute (NCI), American Society for Clinical Oncology (ASCO), American Urological Association (AUA), and other institutions on research projects. KCA educates families and physicians, and serves as an advocate on behalf of patients at the state and federal levels.